Suspension de la négociation par l'Organisme canadien de réglementation des investissements - EVMT Canada NewsWire VANCOUVER, BC, le 2 avril 2024 VANCOUVER, BC, le 2 avril 2024...
Canadian Investment Regulatory Organization Trading Halt - EVMT Canada NewsWire VANCOUVER, BC, April 2, 2024 VANCOUVER, BC, April 2, 2024 /CNW/ - The following issues have been halted by...
NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) has executed a non-binding letter of intent (LOI) to extend acquisition debt of...
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), is pleased to announce its corporate name change to Evome Medical...
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), announced today it has executed an exclusive distribution agreement with...
NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), announced today the debut of the Biodex Reactive Step Trainer (“RST”): A...
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., today announced the debut...
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., today announced financial...
NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., announced its attendance...
NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD) today announced it has booked a $837,000 order for its Biodex System Pro4™ and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.